Compounds > fluoxetine

fluoxetine and glycolipids

fluoxetine has been researched along with glycolipids in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Farooqui, AA; Lee, LH; Ong, WY; Shui, G; Tan, CH; Wenk, MR1
Ask, KS; Bardakci, T; Gjelstad, A; Halvorsen, TG; Parmer, MP; Pedersen-Bjergaard, S; Øiestad, EL1
Armando, AM; Bi, J; Cloughesy, TF; Cravatt, BF; Curtis, EJ; Furnari, FB; Gimple, RC; Gu, Y; Jing, H; Khan, A; Koga, T; Kornblum, HI; Miki, S; Mischel, PS; Prager, B; Quehenberger, O; Reed, A; Rich, JN; Rzhetsky, A; Tang, J; Wainwright, DA; Wong, IT; Wu, S; Yang, H; Zhang, W1
Bortoli, M; Bright, FO; da Rocha, JBT; Delgado, CP; Nogara, PA; Orian, L; Pauletto, P1

Other Studies

4 other study(ies) available for fluoxetine and glycolipids

ArticleYear
Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long-chain fatty acids?
    The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:7

    Topics: Animals; Antidepressive Agents; Basal Ganglia; Brain; Ceramides; Cerebellum; Chromatography, High Pressure Liquid; Fatty Acids; Fluoxetine; Hippocampus; Injections, Intraperitoneal; Lysophospholipids; Male; Maprotiline; Mice; Mice, Inbred BALB C; Paroxetine; Phosphatidylcholines; Phospholipases A2; Prefrontal Cortex; Spectrometry, Mass, Electrospray Ionization; Sphingomyelins; Time Factors

2009
Parallel artificial liquid membrane extraction as an efficient tool for removal of phospholipids from human plasma.
    Journal of pharmaceutical and biomedical analysis, 2016, Sep-10, Volume: 129

    Topics: Chromatography, Liquid; Fluoxetine; Fluvoxamine; Humans; Lysophosphatidylcholines; Membranes, Artificial; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Plasma; Quetiapine Fumarate; Sphingomyelins; Tandem Mass Spectrometry; Technology, Pharmaceutical

2016
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
    Cell reports, 2021, 11-02, Volume: 37, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Repositioning; Electronic Health Records; Energy Metabolism; ErbB Receptors; Female; Fluoxetine; Glioblastoma; Humans; Mice, Nude; Permeability; Retrospective Studies; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Temozolomide; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021
    Journal of biomolecular structure & dynamics, 2023, Volume: 41, Issue:19

    Topics: Antidepressive Agents; Ceramides; COVID-19; Fluoxetine; Humans; Saposins; SARS-CoV-2; Sphingomyelin Phosphodiesterase; Sphingomyelins

2023